Gene: LUZP2
Official Full Name: leucine zipper protein 2provided by HGNC
Gene Summary: This gene encodes a leucine zipper protein. This protein is deleted in some patients with Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation (WAGR) syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20432 | LUZP2 Knockout cell line (HeLa) | Human | LUZP2 | 1:3~1:6 | Negative | Online Inquiry |
LUZP2 Gene Knockout Cell Lines represent an advanced tool in molecular biology, specifically designed to facilitate the study of gene function, protein interactions, and cellular pathways. These cell lines are generated through precise gene-editing techniques, such as CRISPR-Cas9, resulting in the targeted deletion of the LUZP2 gene. This gene encodes for a protein implicated in various cellular processes, including cell signaling and stress responses. By eliminating this gene, researchers can better understand the role of LUZP2 in normal physiology and its potential contributions to pathological conditions.
The key functions of LUZP2 Gene Knockout Cell Lines lie in their ability to provide insights into gene function and influence on cellular behavior. Researchers can quantitatively assess changes in cell proliferation, apoptosis, and differentiation, thereby elucidating the molecular mechanisms regulated by LUZP2. This understanding is particularly crucial in the context of diseases such as cancer, where aberrant gene expression is commonplace. Furthermore, the knockout cell lines can be effectively utilized in high-throughput screening assays to identify compounds that selectively target LUZP2-associated pathways, making them invaluable in drug discovery efforts.
Scientifically, these cell lines have significant applications both in research laboratories and clinical settings. They enable researchers to explore gene functions in a controlled environment, aiding in the investigation of genetic disorders, cellular stress responses, and therapeutic interventions. The ability to perform comparative studies with wild-type control lines enhances the robustness of biological findings, paving the way for potential translational applications in personalized medicine.
What sets LUZP2 Gene Knockout Cell Lines apart from alternatives is their specificity and reliability. Developed through rigorous quality control processes, these cell lines ensure minimal off-target effects, allowing for precise experimental outcomes. Additionally, our comprehensive support and consultation services empower researchers to maximize the utility of our product, enhancing experimental design, data interpretation, and subsequent applications.
For researchers and clinicians dedicated to advancing our understanding of gene functions and disease mechanisms, LUZP2 Gene Knockout Cell Lines are an essential addition to their cellular toolkit. Our company boasts extensive expertise in the generation of high-fidelity gene knockout models, with a commitment to delivering superior biological products that meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.